Ajay Kumar Singh Rawat

Ajay Kumar Singh Rawat

Auto-generated profile, based on publicly available information

Ajay Kumar Singh Rawat

School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow, Uttar Pradesh, 226013, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
RSRajat Srivastava
Rajat Srivastava
ARAjay Kumar Singh Rawat
Ajay Kumar Singh Rawat
MMManoj Kumar Mishra
Manoj Kumar Mishra
APAmit Kumar Patel
Amit Kumar Patel
: Infections caused by fungi can be mildly bothersome or fatal, causing life-threatening conditions or even death. Antifungal drugs have used synthetic chemicals, organic compounds, and phytoconstituents in their formulations to treat fungal infections. Research into novel antifungal drugs has progressed more rapidly than into antibacterial treatments. This can be attributed to the low resistance of fungal infections to antifungal bioactivities and the relatively low incidence of these diseases. Carrier systems based on nanotechnology have generated much interest recently because of the incredible potential of these systems. By using nanoarchitecture as a better carrier and drug delivery system (DDS), we can have greater antifungal effectiveness, bioavailability, targeted action, and less cytotoxicity, a development made possible using nanotechnology. This review discusses various nanocarrier-based technologies in addition to other nanotechnological methods. These include liposomes, transfersomes, ethosomes, niosomes, dendrimers, polymeric nanoparticles, polymer nanocomposites, metallic nanoparticles, carbon nanomaterials, etc. : This review focused on general information regarding fungi infections, different antifungal agent types and mechanisms of action, and an overview of formulation strategies such as nanotechnology systems, which are frequently researched for antifungal therapies. : We concluded that new drug delivery systems are crucial to delivering antifungal medicines to their target site with the optimum concentration. The researchers also concentrated on these innovative drug delivery systems, which primarily focus on regulating and maintaining the release of antifungal drugs.

1 September 2007 in JPC – Journal of Planar Chromatography – Modern TLC
Verified
Journal Article
Closed access
SSSharad Srivastava
Sharad Srivastava
ARAjay Rawat
Ajay Rawat